Mutation, deletion, or epigenetic silencing of PTEN has been shown to correlate with poor prognosis and reduced survival in patients with various types of cancer [36], with loss of PTEN being a common mechanism for activation of the PI3K/Akt/mTOR pathway and poor prognosis. The gene discussed is MTOR; the disease is cancer.